Shozo Aoki

475 total citations
23 papers, 306 citations indexed

About

Shozo Aoki is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shozo Aoki has authored 23 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shozo Aoki's work include Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (6 papers) and Treatment of Major Depression (6 papers). Shozo Aoki is often cited by papers focused on Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (6 papers) and Treatment of Major Depression (6 papers). Shozo Aoki collaborates with scholars based in Japan, Malaysia and Sweden. Shozo Aoki's co-authors include Hiroshi Ueno, Shunsuke Suemitsu, Kenta Wani, Naoya Kitamura, Shinji Murakami, Takeshi Ishihara, Motoi Okamoto, Shigetoshi Kuroda, Keizo Takao and Shosuke Watanabe and has published in prestigious journals such as Brain Research, Journal of Affective Disorders and Biological and Pharmaceutical Bulletin.

In The Last Decade

Shozo Aoki

23 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shozo Aoki Japan	11	91	78	61	57	53	23	306
Branislav Mancevski United States	10	108 1.2×	90 1.2×	36 0.6×	83 1.5×	26 0.5×	13	339
Aurelia Viglione Italy	10	83 0.9×	21 0.3×	23 0.4×	43 0.8×	35 0.7×	17	348
Claudia Kriegebaum Germany	6	251 2.8×	75 1.0×	19 0.3×	133 2.3×	61 1.2×	8	458
David Pritchett United Kingdom	11	71 0.8×	40 0.5×	26 0.4×	49 0.9×	33 0.6×	16	389
William Boshoven United States	11	142 1.6×	70 0.9×	31 0.5×	46 0.8×	38 0.7×	14	380
M.F. Gosso Netherlands	7	38 0.4×	85 1.1×	44 0.7×	60 1.1×	44 0.8×	12	363
J. Miguel Cisneros-Franco Canada	10	134 1.5×	106 1.4×	17 0.3×	55 1.0×	20 0.4×	21	431
David Ladrón de Guevara‐Miranda Spain	10	160 1.8×	28 0.4×	20 0.3×	76 1.3×	18 0.3×	20	340
Margaret Madigan United States	11	141 1.5×	121 1.6×	11 0.2×	32 0.6×	58 1.1×	22	357
Kayvon Salimi United States	9	138 1.5×	92 1.2×	11 0.2×	107 1.9×	68 1.3×	10	520

Countries citing papers authored by Shozo Aoki

Since Specialization

Citations

This map shows the geographic impact of Shozo Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shozo Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shozo Aoki more than expected).

Fields of papers citing papers by Shozo Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shozo Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shozo Aoki. The network helps show where Shozo Aoki may publish in the future.

Co-authorship network of co-authors of Shozo Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Shozo Aoki. A scholar is included among the top collaborators of Shozo Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shozo Aoki. Shozo Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Himi, Naoyuki, N. Okabe, Kazuhiko Narita, et al.. (2020). Ryanodine receptors are involved in the improvement of depression-like behaviors through electroconvulsive shock in stressed mice. Brain stimulation. 14(1). 36–47. 7 indexed citations

Aoki, Shozo, et al.. (2019). Association between previous high-dose antipsychotic therapy and brexpiprazole discontinuation after the initiation of brexpiprazole in patients with schizophrenia or schizoaffective disorder. International Clinical Psychopharmacology. 35(2). 98–104. 7 indexed citations

Ueno, Hiroshi, Shunsuke Suemitsu, Shinji Murakami, et al.. (2018). Juvenile stress induces behavioral change and affects perineuronal net formation in juvenile mice. BMC Neuroscience. 19(1). 41–41. 34 indexed citations

Kishi, Yoshiki, et al.. (2018). Two-year effectiveness of risperidone and aripiprazole in the maintenance treatment of patients with recent-onset or chronic schizophrenia and related psychotic disorders. International Clinical Psychopharmacology. 33(3). 147–154. 1 indexed citations

Ueno, Hiroshi, Shunsuke Suemitsu, Shinji Murakami, et al.. (2018). Hyaluronic acid is present on specific perineuronal nets in the mouse cerebral cortex. Brain Research. 1698. 139–150. 7 indexed citations

Ueno, Hiroshi, Kazuki Fujii, Shunsuke Suemitsu, et al.. (2018). Expression of aggrecan components in perineuronal nets in the mouse cerebral cortex. IBRO Reports. 4. 22–37. 36 indexed citations

Nakagawa, Akiko, Nora Choque Olsson, Tetsuji Miyazaki, et al.. (2018). Long-term outcome of CBT in adults with OCD and comorbid ASD: A naturalistic follow-up study. Current Psychology. 38(6). 1763–1771. 5 indexed citations

Ueno, Hiroshi, Shunsuke Suemitsu, Shinji Murakami, et al.. (2018). Empathic behavior according to the state of others in mice. Brain and Behavior. 8(7). e00986–e00986. 19 indexed citations

Ueno, Hiroshi, Keizo Takao, Shunsuke Suemitsu, et al.. (2017). Age-dependent and region-specific alteration of parvalbumin neurons and perineuronal nets in the mouse cerebral cortex. Neurochemistry International. 112. 59–70. 52 indexed citations

10.

Ueno, Hiroshi, et al.. (2017). Postnatal development of GABAergic interneurons and perineuronal nets in mouse temporal cortex subregions. International Journal of Developmental Neuroscience. 63(1). 27–37. 11 indexed citations

11.

Kishi, Yoshiki, et al.. (2017). Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders. Journal of Clinical Psychopharmacology. 37(3). 296–301. 4 indexed citations

12.

Nishida, Atsushi, et al.. (2004). Characteristics and outcomes of school refusal in Hiroshima, Japan: proposals for network therapy.. PubMed. 58(5). 241–9. 21 indexed citations

13.

Aoki, Shozo, et al.. (2002). Effects of tricyclic antidepressants on protein kinase C activity in rabbit and human platelets in vivo. Journal of Affective Disorders. 70(3). 329–332. 10 indexed citations

14.

Aoki, Shozo, et al.. (2002). Clonazepam augmentation of antidepressants: does it distinguish unipolar from bipolar depression?. Journal of Affective Disorders. 71(1-3). 217–220. 10 indexed citations

15.

Aoki, Shozo, et al.. (1999). Clonazepam in the treatment of prolonged depression. Journal of Affective Disorders. 53(3). 275–278. 13 indexed citations

16.

Aoki, Shozo, et al.. (1999). Different effect of desipramine on protein kinase C in platelets between bipolar and major depressive disorders. Psychiatry and Clinical Neurosciences. 53(1). 11–15. 12 indexed citations

17.

Aoki, Shozo, et al.. (1998). Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders. Psychiatry and Clinical Neurosciences. 52(1). 75–78. 13 indexed citations

18.

Fujiwara, Yutaka, et al.. (1998). Comparison of Early- and Late-Onset Rapid Cycling Affective Disorders. Journal of Clinical Psychopharmacology. 18(4). 282–288. 10 indexed citations

19.

Suzuki, Hiroshi, et al.. (1998). Delusions and hallucinations in patients with borderline personality disorder. Psychiatry and Clinical Neurosciences. 52(6). 605–610. 10 indexed citations

20.

Aoki, Shozo, Hiromune Ando, Masaaki Ishii, et al.. (1994). Evaluation of the Correlation between in Vivo and in Vitro Release. Effect of the Force of Contraction and Food on Drug Release.. Biological and Pharmaceutical Bulletin. 17(2). 291–295. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact